1Haddad RI,Shin DM.Recent advances in head and neck cancer.N EnglJ Med,2008,35(9):1143-1154.
2Khanfir A,Frikha M,Ghorbel A,et al.Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer Radiother,2007,11 (8) :461 -464.
3Mileshkin L, Rischin D. Gemcitabine for patients with relapsed nasopharyngeal carcinoma. Intern Meal J. 2002,32(5-6):275-276.
4Foo KF,Tan EH,Leong SS,et al.Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type.AnnOncol, 2002,13(1):150-156.
5Raymond E,Faivre S,Woynarowski JM,et al.Oxaliplatin: mechanism of action and antineoplastic activity.Semin Oncol 1999,25:4-12.
6Zhang L,Zhao C,Peng PJ,et al.Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma:preliminary results.J Clin Onco12005,23:8461-8468.
